Evomics deploys AI and nuclear medicine in the fight against cancer
AI and nuclear medicine Some of the most innovative uses of artificial intelligence in healthcare today are in the field of nuclear medicine, and thanks to AI, nuclear medicine is demonstrating great potential for cancer treatment. There are around 20 million new cancer cases a year, and around 10 million deaths, which is around one in six of all deaths. The problem, and therefore the opportunity, is vast. One of the leading companies in the field is Evomics, based in Shanghai and Vienna. It is using the same technology to develop both diagnostics and therapies, and it has ambitious plans...